{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:00:28Z","timestamp":1768820428447,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1186\/s12859-018-2070-0","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T09:01:27Z","timestamp":1525770087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hierarchical structural component modeling of microRNA-mRNA integration analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Yongkang","family":"Kim","sequence":"first","affiliation":[]},{"given":"Sungyoung","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Sungkyoung","family":"Choi","sequence":"additional","affiliation":[]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[]},{"given":"Taesung","family":"Park","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"issue":"Suppl 3","key":"2070_CR1","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/bcr2431","volume":"11","author":"JS Reis-Filho","year":"2009","unstructured":"Reis-Filho JS. Next-generation sequencing. Breast Cancer Res. 2009;11(Suppl 3):S12.","journal-title":"Breast Cancer Res"},{"issue":"21","key":"2070_CR2","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","volume":"21","author":"C Bock","year":"2005","unstructured":"Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21(21):4067\u20138.","journal-title":"Bioinformatics"},{"issue":"4","key":"2070_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","volume":"5","author":"L Anderson","year":"2006","unstructured":"Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics. 2006;5(4):573\u201388.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"2070_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nrm1857","volume":"7","author":"AR Joyce","year":"2006","unstructured":"Joyce AR, Palsson BO. The model organism as a system: integrating \u2018omics\u2019 data sets. Nat Rev Mol Cell Bio. 2006;7(3):198\u2013210.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"2070_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","volume":"774","author":"TA Farazi","year":"2013","unstructured":"Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. Adv Exp Med Biol. 2013;774:1\u201320.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"2070_CR6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1177\/1535370214533887","volume":"239","author":"SM Kang","year":"2014","unstructured":"Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med. 2014;239(11):1505\u201313.","journal-title":"Exp Biol Med"},{"issue":"5","key":"2070_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3349\/ymj.2010.51.5.622","volume":"51","author":"A Navarro","year":"2010","unstructured":"Navarro A, Monzo M. MicroRNAs in human embryonic and cancer stem cells. Yonsei Med J. 2010;51(5):622\u201332.","journal-title":"Yonsei Med J"},{"issue":"11","key":"2070_CR8","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1242\/jcs.03450","volume":"120","author":"M Negrini","year":"2007","unstructured":"Negrini M, Ferracin M, Sabbioni S, Croce CM. MicroRNAs in human cancer: from research to therapy. J Cell Sci. 2007;120(11):1833\u201340.","journal-title":"J Cell Sci"},{"issue":"Web Server issu","key":"2070_CR9","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkp294","volume":"37","author":"S Nam","year":"2009","unstructured":"Nam S, Li M, Choi K, Balch C, Kim S, Nephew KP. MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res. 2009;37(Web Server issue):W356\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2070_CR10","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1158\/0008-5472.CAN-11-0489","volume":"71","author":"FM Buffa","year":"2011","unstructured":"Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 2011;71(17):5635\u201345.","journal-title":"Cancer Res"},{"key":"2070_CR11","first-page":"8","volume":"4","author":"JH Cho","year":"2011","unstructured":"Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, et al. Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med Genet. 2011;4:8.","journal-title":"BMC Med Genet"},{"issue":"1","key":"2070_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF02295841","volume":"69","author":"HS Hwang","year":"2004","unstructured":"Hwang HS, Takane Y. Generalized structured component analysis. Psychometrika. 2004;69(1):81\u201399.","journal-title":"Psychometrika"},{"issue":"17","key":"2070_CR13","doi-asserted-by":"publisher","first-page":"i586","DOI":"10.1093\/bioinformatics\/btw425","volume":"32","author":"S Lee","year":"2016","unstructured":"Lee S, Choi S, Kim YJ, Kim BJ, Consortium T-G, Hwang H, Park T. Pathway-based approach using hierarchical components of collapsed rare variants. Bioinformatics. 2016;32(17):i586\u201394.","journal-title":"Bioinformatics"},{"issue":"1","key":"2070_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. Ca Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"Ca Cancer J Clin"},{"issue":"11","key":"2070_CR15","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"2","key":"2070_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4143\/crt.2016.089","volume":"48","author":"CM Oh","year":"2016","unstructured":"Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, Lee DH, Lee KH, Community of Population-Based Regional Cancer R. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2):436\u201350.","journal-title":"Cancer Res Treat"},{"issue":"7467","key":"2070_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328\u201337.","journal-title":"Nature"},{"issue":"6","key":"2070_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/jgh.13253","volume":"31","author":"J Namkung","year":"2016","unstructured":"Namkung J, Kwon W, Choi Y, Yi SG, Han S, Kang MJ, Kim SW, Park T, Jang JY. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value. J Gastroenterol Hepatol. 2016;31(6):1160\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"2070_CR19","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. elife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"issue":"1","key":"2070_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J Roy Stat Soc B Met. 1996;58(1):267\u201388.","journal-title":"J Roy Stat Soc B Met"},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc B. 2005;67:301\u201320.","journal-title":"J R Stat Soc B"},{"key":"2070_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1467-9868.2007.00627.x","volume":"70","author":"L Meier","year":"2008","unstructured":"Meier L, van de Geer SA, Buhlmann P. The group lasso for logistic regression. J R Stat Soc B. 2008;70:53\u201371.","journal-title":"J R Stat Soc B"},{"issue":"Suppl 9","key":"2070_CR23","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2164-16-S9-S4","volume":"16","author":"MS Kwon","year":"2015","unstructured":"Kwon MS, Kim Y, Lee S, Namkung J, Yun T, Yi SG, Han S, Kang M, Kim SW, Jang JY, et al. Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer. BMC Genomics. 2015;16(Suppl 9):S4.","journal-title":"BMC Genomics"},{"issue":"1\u20132","key":"2070_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1\u20132):279\u201384.","journal-title":"Behav Brain Res"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chemosphere.2017.05.152","volume":"184","author":"D Yang","year":"2017","unstructured":"Yang D, Ma M, Zhou W, Yang B, Xiao C. Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells. Chemosphere. 2017;184:289\u201398.","journal-title":"Chemosphere"},{"key":"2070_CR26","doi-asserted-by":"publisher","unstructured":"Chen R, Liao JY, Huang J, Chen WL, Ma XJ, Luo XD. Downregulation of SRC kinase signaling inhibitor 1 (SRCIN1) expression by MicroRNA-32 promotes proliferation and epithelial-mesenchymal transition in human liver cancer cells. Oncol Res; 2017. https:\/\/doi.org\/10.3727\/096504017X14954923820137 .","DOI":"10.3727\/096504017X14954923820137"},{"issue":"11","key":"2070_CR27","doi-asserted-by":"publisher","first-page":"e0165776","DOI":"10.1371\/journal.pone.0165776","volume":"11","author":"S Chen","year":"2016","unstructured":"Chen S, Chen X, Sun KX, Xiu YL, Liu BL, Feng MX, Sang XB, Zhao Y. MicroRNA-93 promotes epithelial-mesenchymal transition of endometrial carcinoma cells. PLoS One. 2016;11(11):e0165776.","journal-title":"PLoS One"},{"issue":"6","key":"2070_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/onc.2014.11","volume":"34","author":"F Lahdaoui","year":"2015","unstructured":"Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchene B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N, et al. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Oncogene. 2015;34(6):780\u20138.","journal-title":"Oncogene"},{"issue":"2","key":"2070_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/ijo.2013.2189","volume":"44","author":"L Xu","year":"2014","unstructured":"Xu L, Li Q, Xu D, Wang Q, An Y, Du Q, Zhang J, Zhu Y, Miao Y. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol. 2014;44(2):459\u201366.","journal-title":"Int J Oncol"},{"issue":"1","key":"2070_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.24687","volume":"126","author":"T Greither","year":"2010","unstructured":"Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer. 2010;126(1):73\u201380.","journal-title":"Int J Cancer"},{"issue":"4","key":"2070_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12032-013-0700-y","volume":"30","author":"CL Lee","year":"2013","unstructured":"Lee CL, He H, Jiang YJ, Di Y, Yang F, Li J, Jin C, Fu DL. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Med Oncol. 2013;30(4):700.","journal-title":"Med Oncol"},{"issue":"4","key":"2070_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2011.02.065","volume":"406","author":"JK Park","year":"2011","unstructured":"Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun. 2011;406(4):518\u201323.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2070_CR33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/carcin\/bgr105","volume":"32","author":"S Zhang","year":"2011","unstructured":"Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 2011;32(8):1183\u20139.","journal-title":"Carcinogenesis"},{"issue":"14","key":"2070_CR34","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.18632\/oncotarget.2200","volume":"5","author":"J Feng","year":"2014","unstructured":"Feng J, Yu J, Pan X, Li Z, Chen Z, Zhang W, Wang B, Yang L, Xu H, Zhang G, et al. HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Oncotarget. 2014;5(14):5832\u201344.","journal-title":"Oncotarget"},{"issue":"37","key":"2070_CR35","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1038\/onc.2014.408","volume":"34","author":"I Keklikoglou","year":"2015","unstructured":"Keklikoglou I, Hosaka K, Bender C, Bott A, Koerner C, Mitra D, Will R, Woerner A, Muenstermann E, Wilhelm H, et al. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes. Oncogene. 2015;34(37):4867\u201378.","journal-title":"Oncogene"},{"key":"2070_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2017.03.019","volume":"177","author":"S Hu","year":"2017","unstructured":"Hu S, Zheng Q, Wu H, Wang C, Liu T, Zhou W. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci. 2017;177:15\u20139.","journal-title":"Life Sci"},{"issue":"3","key":"2070_CR37","doi-asserted-by":"publisher","first-page":"e0173912","DOI":"10.1371\/journal.pone.0173912","volume":"12","author":"L Bai","year":"2017","unstructured":"Bai L, Wang H, Wang AH, Zhang LY, Bai J. MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer. PLoS One. 2017;12(3):e0173912.","journal-title":"PLoS One"},{"issue":"4","key":"2070_CR38","doi-asserted-by":"publisher","first-page":"101042831769757","DOI":"10.1177\/1010428317697570","volume":"39","author":"A Sheikholeslami","year":"2017","unstructured":"Sheikholeslami A, Nabiuni M, Arefian E. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590. Tumour Biol. 2017;39(4):1010428317697570.","journal-title":"Tumour Biol"},{"key":"2070_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/CBM-160421","volume":"19","author":"D Yang","year":"2017","unstructured":"Yang D, Zhao D, Chen X. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression. Cancer Biomark. 2017;19:425.","journal-title":"Cancer Biomark"},{"key":"2070_CR40","doi-asserted-by":"crossref","first-page":"50193","DOI":"10.18632\/oncotarget.16745","volume":"8","author":"D Li","year":"2017","unstructured":"Li D, Xia L, Chen M, Lin C, Wu H, Zhang Y, Pan S, Li X. miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer. Oncotarget. 2017;8:50193.","journal-title":"Oncotarget"},{"issue":"49","key":"2070_CR41","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1021\/acs.jafc.6b04549","volume":"64","author":"H Wu","year":"2016","unstructured":"Wu H, Wang Y, Wu C, Yang P, Li H, Li Z. Resveratrol induces cancer cell apoptosis through MiR-326\/PKM2-mediated ER stress and mitochondrial fission. J Agric Food Chem. 2016;64(49):9356\u201367.","journal-title":"J Agric Food Chem"},{"key":"2070_CR42","doi-asserted-by":"crossref","unstructured":"Ji S, Zhang B, Kong Y, Ma F, Hua Y. MiR-326 inhibits gastric cancer cell growth through down regulating NOB1. Oncol Res. 2017;25(6):53\u201386.","DOI":"10.3727\/096504016X14759582767486"},{"issue":"12","key":"2070_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2070-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:04:44Z","timestamp":1720281884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2070-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":43,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2070-0","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"8 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Between the years 2009 and 2012, 200 pancreatic ductal adenocarcinoma (PDAC) samples were collected by the Department of Hepatobiliary and Pancreas Surgery of Seoul National University Hospital. The study protocol was approved by the Institutional Review Board of Seoul National University Hospital (IRB H-0901-010-267) and written, informed consent was obtained from each patient or legally authorized representative.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}